| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046613A1 Il-18-like peptide, fused peptide thereof, method of producing the same and use of the same |
| 05/04/2006 | WO2006046603A1 Islet transplantation auxiliary |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094737 Novel uracil derivatives and medicinal use thereof |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094677 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2584752A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/03/2006 | EP1652530A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651647A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 05/03/2006 | EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651609A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651608A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651266A1 Administration of anti-cytokine f(ab')2 antibody fragments |
| 05/03/2006 | EP1651257A1 Targeted therapeutic vaccine against p-glycoprotein 170 for inhibiting multi-drug resistance in the treatment of cancers |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1651212A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 05/03/2006 | EP1651198A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1346987B1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1189611B1 Cancer therapy |
| 05/03/2006 | EP1043021B1 Purine derivatives for the treatment of allergic diseases and systemic lupus erythematosus |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768072A Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 05/03/2006 | CN1768049A 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/03/2006 | CN1767870A Otorhinological delivery device |
| 05/03/2006 | CN1767840A Method of enhancing autoimmunity |
| 05/03/2006 | CN1767839A Antiallergic composition |
| 05/03/2006 | CN1767819A Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/03/2006 | CN1766114A Plasmid containing recombinant immunological toxin MIP-1ª‡-DT390 aiming at activated Th1 cell, its preparation method and uses |
| 05/03/2006 | CN1765371A Spleen extracts, its preparation method and use |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254475C 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254261C Medicine for increasing organism immunological functioning and preparing method thereof |
| 05/03/2006 | CN1254238C Use of Wangzaozi secondary element as immunological inhibitors pharmaceuticals |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/03/2006 | CN1254199C Multi-purpose high-function alkaline solution composition, its preparing process and its usage as non-specific immanopotentiator |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038049 Anticancer agents; antitumor agents; apoptosis of breast tumor cells; drug resistance leukemia |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7038017 Antibody purification |
| 05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037507 T helper cell epitopes |
| 05/02/2006 | US7037505 interlkeukins (IL-8); tumor necrosis factor (TNF); improved cytokine activity, immune response |
| 05/02/2006 | US7037500 Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity |
| 05/02/2006 | US7037499 Adjuvant for transcutaneous immunization |
| 04/27/2006 | WO2006043891A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| 04/27/2006 | WO2006043783A1 Pharmaceutical compositions, comprising red ginseng acid polysaccharide and lentinus edodes, of preventing and treating cancer |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043615A1 Use of immunesuppressant receptor |
| 04/27/2006 | WO2006043477A1 Nerve growth factor production inhibitor and external preparation for the skin, cosmetic, quasi drug, preventive and remedy for itching and remedy for atopic dermatitis containing the nerve growth factor production inhibitor |
| 04/27/2006 | WO2006042857A2 Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | WO2006042408A1 Gh secretagogues and uses thereof |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | WO2006003407A3 Chimeric and humanised monoclonal antibodies against inteleukin- 13 |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |